| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $433 | -87.4% |
| Gross Profit | $433 | +100.1% |
| R&D Expense | $168K | -42.8% |
| Operating Income | -$949K | +3.6% |
| Net Income | -$963K | -11.3% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14K | -95.2% |
| Current Assets | $92K | -76.9% |
| Total Assets | $92K | -81.0% |
| Current Liabilities | $978K | +87.9% |
| Total Liabilities | $978K | +87.9% |
| Stockholders' Equity | -$886K | -2368.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$281K | +64.1% |
| Investing Cash Flow | -$9K | -105.8% |
| Financing Cash Flow | $9K | +0.0% |